TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
GENB

Generate Biomedicines, Inc.

Healthcare · Biotechnology

16.50$ -5.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement GENB
Line item 2024 2025
+55.9%
+55.9%
+28.2%
+0.4%
+22.8%
-46.4%
-23.1%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?